Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457730 · ClinicalTrials.gov registry record · Phase 2
A Study to Test the Use of Duloxetine for Pain in MS
A Phase 2 study, sponsored by Brown, Theodore R., M.D., MPH.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT00457730 is a Phase 2 study that has completed, run by Brown, Theodore R., M.D., MPH. The registered enrollment target is 38 participants.
The verdict
NCT00457730, a Phase 2 study, has completed, sponsored by Brown, Theodore R., M.D., MPH.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
Many patients with Multiple Sclerosis experience pain that is caused by the effects of MS on the nervous system. The purpose of this study is to see if an investigational drug (Duloxetine) will reduce pain in subjects with MS. The US Food and Drug administration (FDA) has approved this drug for use with depression or pain from diabetes.However, it is considered investigational for this study because it has not been approved for patients with MS. This study will recruit patients with MS who have central pain which is 4 or greater on a scale of 1-10. Patients must have experienced pain for 2 months or longer prior to begining the study.The study will last 10 weeks, patients will be randomized either Duloxetine or placebo and will be carefully monitored throughout the study. Patients will keep pain/sleep diaries during the study period and will be provided Ibuprofen for pain control.
Interventions
- DRUG Placebo
- DRUG Duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2007-01 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457730
The ClinicalTrials.gov registry entry for NCT00457730 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown, Theodore R., M.D., MPH, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00457730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00457730 about?
NCT00457730 is a clinical study titled "A Study to Test the Use of Duloxetine for Pain in MS". Many patients with Multiple Sclerosis experience pain that is caused by the effects of MS on the nervous system. The purpose of this study is to see if an investigational drug (Duloxetine) will reduce pain in subjects with MS. The US Food and Drug administration (FDA) has approved this drug for us...
What is the current status of trial NCT00457730?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2007-01. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00457730?
The interventions under investigation include: Placebo (DRUG), Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00457730?
This trial is sponsored by Brown, Theodore R., M.D., MPH, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.